Access to anti-retroviral drugs, female in Lebanon
Lebanon: Access to anti-retroviral drugs, female was 69.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, female in Lebanon, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
The most recent figure for access to anti-retroviral drugs, female in Lebanon is 69.0%, measured in 2024. That is the highest value across all 25 years on record.
Compared with earlier readings it is up 4.5% on the previous year and up 102.9% over ten years.
Over the whole period, access to anti-retroviral drugs, female in Lebanon peaked at 69.0% in 2024 and was at its lowest, 4.0%, in 2000.
That places Lebanon 84th out of 141 countries with data for 2024, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, female in Lebanon, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 4.0% | — |
| 2001 | 7.0% | +75.0% |
| 2002 | 11.0% | +57.1% |
| 2003 | 14.0% | +27.3% |
| 2004 | 17.0% | +21.4% |
| 2005 | 18.0% | +5.9% |
| 2006 | 20.0% | +11.1% |
| 2007 | 22.0% | +10.0% |
| 2008 | 23.0% | +4.5% |
| 2009 | 28.0% | +21.7% |
| 2010 | 32.0% | +14.3% |
| 2011 | 35.0% | +9.4% |
| 2012 | 36.0% | +2.9% |
| 2013 | 33.0% | -8.3% |
| 2014 | 34.0% | +3.0% |
| 2015 | 38.0% | +11.8% |
| 2016 | 48.0% | +26.3% |
| 2017 | 50.0% | +4.2% |
| 2018 | 56.0% | +12.0% |
| 2019 | 63.0% | +12.5% |
| 2020 | 67.0% | +6.3% |
| 2021 | 66.0% | -1.5% |
| 2022 | 66.0% | +0.0% |
| 2023 | 66.0% | +0.0% |
| 2024 | 69.0% | +4.5% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 16.4% | 4.0% | 28.0% | 10 |
| 2010s | 42.5% | 32.0% | 63.0% | 10 |
| 2020s | 66.8% | 66.0% | 69.0% | 5 |
Countries ranked near Lebanon
- 81 Lao People's Democratic Republic 71.0% compare
- 82 Estonia 70.0% compare
- 82 Somalia 70.0% compare
- 84 Serbia 69.0% compare
- 86 Dominican Republic 68.0% compare
- 86 Mauritania 68.0% compare
More gender data for Lebanon
- Child population (UN estimates and projections) 1,385 (2030)
- Child population (UN estimates and projections) (0-14), annual growth -1.26 % change on previous year (2030)
- Population 4,719 (2030)
- Working-age population (UN estimates and projections) 4,719 (2030)
- Population (UN estimates and projections), annual growth rate 1.53 % change on previous year (2030)
- Age population, age 00, female, interpolated 44,373 (2025)
- Age population, age 00, male, interpolated 46,608 (2025)
- Age population, age 01, female, interpolated 44,213 (2025)
- Age population, age 01, male, interpolated 46,432 (2025)
- Age population, age 02, female, interpolated 44,307 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, female in Lebanon?
- Access to anti-retroviral drugs, female in Lebanon was 69.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, female recorded in Lebanon?
- The highest recorded value was 69.0% in 2024.
- What is the lowest access to anti-retroviral drugs, female recorded in Lebanon?
- The lowest recorded value was 4.0% in 2000.
- How does Lebanon rank for access to anti-retroviral drugs, female?
- Lebanon ranks 84th out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, female rising or falling in Lebanon?
- Over the last ten years it is up 102.9%. The long-run trend across the full record is volatile.
- Where does this Lebanon data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.